94 related articles for article (PubMed ID: 2495620)
1. HLA linkage of warts and basal cell carcinomas in renal transplant recipients.
Welsh KI; Higgins E; Tidman M; Cameron JS; Koffman CG; Ogg CS; Williams DG
Transplant Proc; 1989 Feb; 21(1 Pt 1):579. PubMed ID: 2495620
[No Abstract] [Full Text] [Related]
2. The different telomere lengths in basal and squamous cell carcinomas also differ between the nontransplant and renal transplant population.
Perrem K; Lynch A; Al Nooh F; Leader M; Elaine Kay
Hum Pathol; 2008 Jul; 39(7):1034-41. PubMed ID: 18482746
[TBL] [Abstract][Full Text] [Related]
3. Pharmacodynamic immune monitoring of NFAT-regulated genes predicts skin cancer in elderly long-term renal transplant recipients.
Sommerer C; Hartschuh W; Enk A; Meuer S; Zeier M; Giese T
Clin Transplant; 2008; 22(5):549-54. PubMed ID: 18394001
[TBL] [Abstract][Full Text] [Related]
4. Basal cell carcinomas developing in solid organ transplant recipients: clinicopathologic study of 176 cases.
Kanitakis J; Alhaj-Ibrahim L; Euvrard S; Claudy A
Arch Dermatol; 2003 Sep; 139(9):1133-7. PubMed ID: 12975154
[TBL] [Abstract][Full Text] [Related]
5. Divergence between the high rate of p53 mutations in skin carcinomas and the low prevalence of anti-p53 antibodies.
Moch C; Moysan A; Lubin R; de la Salmonière P; Soufir N; Galisson F; Vilmer C; Venutolo E; Le Pelletier F; Janin A; Basset-Séguin N
Br J Cancer; 2001 Dec; 85(12):1883-6. PubMed ID: 11747330
[TBL] [Abstract][Full Text] [Related]
6. The +61 A-G polymorphism of the epidermal growth factor gene is not associated with occurrence of non-melanocytic skin tumors in transplant recipients.
Tartaglia S; Belloni-Fortina A; Stefano P; Tessari G; Naldi L; Tenconi R; Clementi M
J Dermatol Sci; 2007 May; 46(2):147-9. PubMed ID: 17223314
[No Abstract] [Full Text] [Related]
7. Relation between skin cancer, humoral responses to human papillomaviruses, and HLA class II molecules in renal transplant recipients.
Bavinck JN; Gissmann L; Claas FH; Van der Woude FJ; Persijn GG; Ter Schegget J; Vermeer BJ; Jochmus I; Müller M; Steger G
J Immunol; 1993 Aug; 151(3):1579-86. PubMed ID: 8393047
[TBL] [Abstract][Full Text] [Related]
8. Immunosuppressive level and other risk factors for basal cell carcinoma and squamous cell carcinoma in heart transplant recipients.
Fortina AB; Piaserico S; Caforio AL; Abeni D; Alaibac M; Angelini A; Iliceto S; Peserico A
Arch Dermatol; 2004 Sep; 140(9):1079-85. PubMed ID: 15381547
[TBL] [Abstract][Full Text] [Related]
9. Basal cell carcinomas, coarse sparse hair, and milia.
Oley CA; Sharpe H; Chenevix-Trench G
Am J Med Genet; 1992 Jul; 43(5):799-804. PubMed ID: 1642265
[No Abstract] [Full Text] [Related]
10. Toll-like receptor 4, 7 and 8 polymorphisms have no association with nonmelanoma skin cancer in renal transplant patients.
Laing ME; Dicker P; Murphy GM
Br J Dermatol; 2009 Sep; 161(3):715-7. PubMed ID: 19614650
[No Abstract] [Full Text] [Related]
11. Overlap between the Bazex syndrome and congenital hypotrichosis and milia.
Lacombe D; Taïeb A
Am J Med Genet; 1995 May; 56(4):423-4. PubMed ID: 7677860
[No Abstract] [Full Text] [Related]
12. Expression of HLA class I and class II genes in patients with multiple skin warts.
Gülseren D; Tan Ç; Yaz İ; Özbek B; Çağdaş D; Tezcan İ
Exp Dermatol; 2021 Nov; 30(11):1642-1649. PubMed ID: 33896076
[TBL] [Abstract][Full Text] [Related]
13. Langerhans cells in benign, premalignant and malignant skin lesions of renal transplant recipients and the effect of retinoid therapy.
Gibson GE; O'Grady A; Kay EW; Leader M; Murphy GM
J Eur Acad Dermatol Venereol; 1998 Mar; 10(2):130-6. PubMed ID: 9553909
[TBL] [Abstract][Full Text] [Related]
14. Active psoriasis and profound CD4+ lymphocytopenia.
Hardman CM; Baker BS; Lortan J; Breuer J; Surentheran T; Powles A; Fry L
Br J Dermatol; 1997 Jun; 136(6):930-2. PubMed ID: 9217828
[TBL] [Abstract][Full Text] [Related]
15. Skin lesions in adult liver transplant recipients: a study of 100 consecutive patients.
Perera GK; Child FJ; Heaton N; O'Grady J; Higgins EM
Br J Dermatol; 2006 May; 154(5):868-72. PubMed ID: 16634888
[TBL] [Abstract][Full Text] [Related]
16. p53-specific serum antibodies are not associated with a history of skin carcinoma in renal transplant recipients and immunocompetent individuals.
de Graaf YG; Schiefer D; Redeker A; Vermeer BJ; Bavinck JN; Willemze R; de Gruijl FR; Van der Burg SH
J Dermatol Sci; 2005 Jun; 38(3):228-30. PubMed ID: 15927816
[No Abstract] [Full Text] [Related]
17. Skin cancer and HLA antigens.
Myskowski PL
N Engl J Med; 1992 Mar; 326(11):765; author reply 766. PubMed ID: 1738388
[No Abstract] [Full Text] [Related]
18. Langerhans cells, immunomodulation and skin lesions. A quantitative, morphological and clinical study.
Bergfelt L
Acta Derm Venereol Suppl (Stockh); 1993; 180():1-37. PubMed ID: 7901956
[TBL] [Abstract][Full Text] [Related]
19. Beta-2-microglobulin and HLA-DR(Ia)-antigens in normal and pathological skin.
Tjernlund U
Acta Derm Venereol Suppl (Stockh); 1981; 94():1-40. PubMed ID: 6169248
[No Abstract] [Full Text] [Related]
20. Absence of human leukocyte antigen molecules in skin tumors and some cutaneous appendages: evidence using monoclonal antibodies.
Holden CA; Sanderson AR; MacDonald DM
J Am Acad Dermatol; 1983 Dec; 9(6):867-71. PubMed ID: 6196384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
